Anticancer potential of soil-associated actinobacterium DHE 6-7 isolated from Enggano Island, Indonesia

Abstract

The growing demand for pharmaceuticals has driven a shift towards developing medicinal products through bioprospecting by utilising sustainable sources. This involves exploring the potential of beneficial bacteria, such as Actinobacteria, known for producing diverse secondary metabolites with medicinal applications. In a previous study, 422 Actinobacteria were successfully isolated from Lombok, Bali, and Enggano Islands in Indonesia, and subjected to various bioactivity tests. Notably, Isolate DHE 6-7 from Enggano Island showed promising potential as a drug candidate. This study aimed to evaluate anticancer activity of DHE 6-7 isolates in T47D breast cancer cell lines and pinpoint the key metabolite contributing to its anticancer activity. The secondary metabolites from the DHE 6-7 culture were extracted using ethyl acetate by liquid-liquid extraction and its bioactive compound was analysed using thin layer chromatography. Subsequently, the extract underwent cytotoxic and antiproliferative assays in T47D cells. While Actinomycin-D was previously identified as a major bioactive compound in methanolic extract of DHE 6-7 isolate, this study confirmed that ethyl acetate extraction was able to retain the Actinomycin-D content from DHE 6-7 isolate. Interestingly however, the ethyl acetate extract of DHE 6-7 (EAE of DHE 6-7) showed superior cytotoxic activity in T47D cells compared to actinomycin-D alone. This may suggest the contribution of additional secondary metabolites in the EAE of DHE 6-7 to its anticancer activity. Notably, the combination of the EAE of DHE 6-7 isolate and 5-FU (5-fluorouracil) exhibited a synergistic effect, indicating the potential use of these compound(s) as a co-chemotherapeutic agent.